pentobarbital will decrease the extent or outcome of bedaquiline by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Prevent coadministration of bedaquiline with potent CYP3A4 inducers on account of probable for lessened therapeutic effectpentobarbital will minimize the level or impact of theophylline by influ